Aggiornamento del 12 dicembre 2021:
Aggiornamento del 19 luglio 2021:
È scaricabile QUI il testo curato da Roberto Hirsch e Héctor Carvallo Ivermectin in COVID-19: prophilaxis & treatment / Ivermectina en COVID-19: profilaxis y tratamiento.
Segnalo il recentissimo Zaidi, A.K., Dehgani-Mobaraki, P., The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article, The Journal of Antibiotics, 15 June 2021.
ABSTRACT
"Considering the urgency of the ongoing COVID-19 pandemic, detection of various new mutant strains and future potential re-emergence of novel coronaviruses, repurposing of approved drugs such as Ivermectin could be worthy of attention. This evidence-based review article aims to discuss the mechanism of action of ivermectin against SARS-CoV-2 and summarizing the available literature over the years. A schematic of the key cellular and biomolecular interactions between Ivermectin, host cell, and SARS-CoV-2 in COVID-19 pathogenesis and prevention of complications have been proposed."
Sull'ivermectina un recente tweet di Robert W Malone, "inventor of mRNA vaccines and RNA as a drug, Bench to Bedside vaccines and biologics consulting."
Vedi anche su questo blog QUI e QUI.
Comments